Detalhe da pesquisa
1.
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch.
J Infect Dis
; 226(10): 1683-1687, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124696
2.
Coronavirus Disease 2019 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida Through August 2021.
Clin Infect Dis
; 75(1): e892-e894, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726700
3.
Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations.
J Intern Med
; 292(1): 127-135, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194861
4.
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
J Infect Dis
; 224(8): 1278-1286, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34279629
5.
Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
J Surg Oncol
; 122(6): 1057-1065, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654173
6.
Establishing Mayo Clinic's Coronavirus Disease 2019 Virtual Clinic: A Preliminary Communication.
Telemed J E Health
; 26(11): 1419-1423, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516070
7.
Intravenous Access in Gastrointestinal Hemorrhage: A Multidisciplinary Quality Improvement Initiative Led by Emergency Department Nurses and Internal Medicine Physicians.
J Nurs Care Qual
; 35(3): E41-E46, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433157
8.
Improving Employee Experience: Reducing Burnout, Decreasing Turnover and Building Well-being.
Clin Gastroenterol Hepatol
; 21(1): 11-14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36155248
9.
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination.
Am J Transplant
; 21(10): 3496-3499, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33890410
10.
COVID-19 Patient Acceptance to Monoclonal Antibody Infusion: A Single Medical Center Experience.
South Med J
; 114(8): 464, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345924
11.
Communication Training Helps to Reduce Burnout During COVID-19 Pandemic.
Health Serv Res Manag Epidemiol
; 10: 23333928221148079, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36756035
12.
Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score.
Mayo Clin Proc Innov Qual Outcomes
; 7(2): 109-121, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644593
13.
Cardiovascular Concerns from COVID-19 in Pilots.
Aerosp Med Hum Perform
; 93(12): 855-865, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757258
14.
SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes.
PNAS Nexus
; 1(3): pgac071, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860600
15.
Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch.
Open Forum Infect Dis
; 9(10): ofac411, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36213724
16.
Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants.
Int J Infect Dis
; 120: 88-95, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487339
17.
Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant.
Mayo Clin Proc
; 97(2): 327-332, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120695
18.
Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.
JAMA Netw Open
; 5(4): e227038, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420661
19.
Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality.
Mayo Clin Proc
; 97(12): 2215-2225, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464463
20.
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.
Med
; 3(1): 28-41.e8, 2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34927113